FMR LLC Reports 10.2% Stake in Charles River Laboratories
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Subscribe to track CRL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Institutional Holding Update: FMR LLC has filed an amended Schedule 13G/A reporting beneficial ownership of 4,865,628.13 shares (10.2%) of Charles River Laboratories International, Inc. ($CRL) as of August 31, 2026.
Comprehensive Analysis
Beneficial Ownership Update: FMR LLC & Charles River Laboratories International, Inc.
Overview
On September 8, 2026, FMR LLC filed Amendment No. 2 to Schedule 13G regarding its stake in Charles River Laboratories International, Inc. ($CRL) with an event date of August 31, 2026.
Key Position Details
- Reporting Persons: FMR LLC, Abigail P. Johnson
- Security: Common Stock (CUSIP: 159864107)
- Aggregate Beneficial Ownership: 4,865,628.13 shares
- Percentage of Class: 10.2%
- Voting Power: Sole voting power over 4,813,779.74 shares; shared voting power over 0 shares
- Dispositive Power: Sole dispositive power over 4,865,628.13 shares; shared dispositive power over 0 shares
Context & Filing Reason
Filed under Rule 13d-1(b) as a passive institutional investor holding more than 10% of the class. Key operating subsidiaries include Fidelity Management & Research Company LLC (which beneficially owns 5% or greater of the outstanding shares), FIAM LLC, and Strategic Advisers LLC.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.